Study finds weakness in drug-resistant tuberculosis pathogens

A University of Otago-led study has found highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, offering a new way to kill them.

Xlife Sciences AG Announces Potential Acquisition of Portfolio Company FUSE-AI GmbH by Pineapple Power Corporation PLC at an Expected Valuation of EUR 80-90 million – Biotech Investments

Xlife Sciences AG / Key word(s): IPO 23-Dec-2024 / 18:35 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is

December 24, 2024

Childhood and adult trauma may play a role in endometriosis pathogenesis

The University of Barcelona has participated in an international study that has found new evidence linking traumatic experiences and stressful events with endometriosis, a chronic

February 7, 2025

NPX-267 by NextPoint Therapeutics for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.